Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...
The US Once again uses the fentanyl issue as a pretext to impose additional tariffs on Chinese exports to the U.S.. China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback